Amgen Inc at Bank of America Global Healthcare Conference Transcript
And thank you for coming out to Las Vegas for the 2023 Healthcare Conference. You are at the first session with Amgen. I'm very pleased today to be joined by Peter Griffith, the CFO; and Dave Reese, Executive VP of R&D, here on stage today.
We do have a couple of prepared remarks from Peter and plenty of time for Q&A. We can go to the crowd for those that have any questions. I'm Dan Lundquist, the BofA health care specialist. So I'm very excited today to kick off the conference. And with that, let me hand it over to Peter.
Dan, thank you very, very much. Good morning, everyone. Great to see all of you. And thank you very much, Bank of America, for hosting us. We're just delighted to be here.
Let's start where we always do at Amgen, and that's with patients. So our mission at Amgen is to discover, develop, manufacture and deliver first-in-class and best-in-class medicines to patients with serious and grievous illnesses all over the world.
And having said that,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |